Utah Medical Products (UTMD) Income from Non-Controlling Interests (2023 - 2024)
Utah Medical Products (UTMD) posted Income from Non-Controlling Interests of -$150000.0 for Q4 2024, down 78.57% on a QoQ basis from -$84000.0 in Q4 2023, and down 78.57% year-over-year from -$700000.0 in Q1 2024.
Powered by 
Analysis
Utah Medical Products (UTMD) Income from Non-Controlling Interests (2023 - 2024) Analysis & Trends
Utah Medical Products has reported Income from Non-Controlling Interests for 2 years, with the latest figure at -$150000.0 in Q4 2024.
- On a quarterly basis, Income from Non-Controlling Interests fell 78.57% year-over-year to -$150000.0 in Q4 2024; TTM through Dec 2024 was -$150000.0, a 78.57% decrease from a year earlier, with the FY2024 full-year figure at -$150000.0, down 78.57% from the prior year.
- Income from Non-Controlling Interests was -$150000.0 for Q4 2024 at Utah Medical Products, down from -$84000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$84000.0 in Q4 2023, with the low at -$150000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.50 Bn | 176.90 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 126.92 Bn | 121.70 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.99 Bn | 109.17 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 104.23 Bn | 100.75 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.98 Bn | 64.44 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.94 Bn | 45.69 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.12 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 900,000.00 |
| 10 | Utah Medical Products | 221.83 Mn | 134.30 Mn | 4.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -150,000.00 |
| Dec 31, 2023 | -84,000.00 |